Medgenics seeks further funding for biopump technology
This article was originally published in Scrip
Executive Summary
Medgenics, the developer of the biopump delivery system for treating chronic disease, is looking to raise $15-20 million by the middle of 2009. The combination biological/device product aims to improve protein delivery for chronic diseases than existing treatments, starting with Epodure, the delivery of erythropoietin (EPO) for anaemia.